Pfg Investments, LLC Altimmune, Inc. Transaction History
Pfg Investments, LLC
- $1.56 Trillion
- Q1 2025
A detailed history of Pfg Investments, LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Pfg Investments, LLC holds 17,500 shares of ALT stock, worth $61,250. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,500
Previous 13,300
31.58%
Holding current value
$61,250
Previous $95.9 Million
8.75%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ALT
# of Institutions
203Shares Held
37.6MCall Options Held
2MPut Options Held
1.69M-
Black Rock Inc. New York, NY5.32MShares$18.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$15.4 Million0.0% of portfolio
-
State Street Corp Boston, MA3.39MShares$11.9 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$9.63 Million0.89% of portfolio
-
Geode Capital Management, LLC Boston, MA1.71MShares$5.97 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $172M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...